Mediar Therapeutics Secures $76 Million Series B Financing to Advance Fibrosis Therapies

Mediar Therapeutics secures a $76 million Series B financing co-led by Amplitude Ventures and ICG, along with new investors.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here